Dr. Philippe Armand discusses the recent FDA approval (June 2018) of Merck’s KEYTRUDA® (pembrolizumab) for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or who have relapsed after two or more prior lines of therapy.
INTERVIEWS
Growing Prevalence of Major Depressive Disorder (MDD) and Treatment Options
Dr. Michael Edward Thase discusses the growing prevalence of major depressive disorder, related misconceptions for HCPs to consider, and the urgent need for alternative treatment options.
Importance of Proper Nutrition to Surgical Patients
Dr. Suela Sulo, PhD, MS, Abbott’s lead nutrition study investigator, discusses importance of surgical patients nutrition new data published in the “Journal of Parenteral and Enteral Nutrition” (JPEN) by Advocate Health Care and supported by Abbott. This data showed that by implementing a nutrition care program that screens patients undergoing surgery for malnutrition and providing nutrition to those at risk, readmission rates went down 50% and their average length of stay after surgery was shortened by 2.7 days.
Dayna Duncan: A Discussion on Rural Health & The Australian Medical Students Association
Third year medical student Dayna Duncan from the Albury Campus of the University of New South Wales joins Health Professional Radio to talk about the Australian Medical Students Association (which she is a member of) and to promote the organization’s Rural Health Summit.
Ubiquinol Shown to Improve Athletic Performance
Nutritionist and Naturopath Stephen Eddey returns to Health Professional Radio to promote the extraordinary health benefits of Ubiquinol and how it can give people (both athletic and non-athletic) that extra energy boost that they need.
KEYTRUDA Treatment of Patients with Recurrent or Metastatic Cervical Cancer
Dr. Bradley Monk, a professor and director of the Division of Gynecologic Oncology at Creighton University School of Medicine St. Joseph’s Hospital and Medical Center in Phoenix, Arizona joins the program to talk about the FDA approval of pembrolizumab (KEYTRUDA) for treatment of patients with recurrent metastatic cervical cancer.
Senhance – Robotic Surgical System to Aide Healthcare Professionals in Surgeries
President and CEO of TransEnterix Inc., Todd Pope, joins Neal Howard on Health Professional Radio to talk about the recent FDA clearance of their company’s inventive Senhance – robotic surgical system which is designed and built to develop the learning curve and be a leverage to healthcare professionals in times of surgeries.
Triage Trak: Improving the Patient Experience with Innovative Triaging and Scheduling Software
Thomas Hofstetter, the Managing Partner of Points Group joins Health Professional Radio to talk about their company’s groundbreaking Triage Trak, a triaging and scheduling software that helps patients to find the perfect doctor and location in order to provide the best patient experience.
FDA-Approval of GORE® CARDIOFORM Septal Occluder
Dr. Scott Kasner discusses this study that led to the recent FDA approval of the GORE® CARDIOFORM Septal Occluder, a device used for the closure of patent foramen ovale (PFO) to reduce the risk of recurrent ischemic stroke in certain patients.
Patient Living with Patent Foramen Ovale (Hole in the heart) & Stroke
Kathryn Dunning, a marathon/trail runner, shares her story of having 2 strokes and finding out about her condition of patent foramen ovale (PFO) closure (a hole in the heart) and the procedure with the GORE® Occluder that has made it possible for her to lead a healthy life without the fear of having a stroke.